Evonik has bought one of its existing portfolio companies, Friedrich Schiller University Jena spinout JeNaCell, for an undisclosed sum.

JeNaCell, a Germany-based developer of biotechnology-derived nanocellulose spun out of Friedrich Schiller University Jena, has been acquired by specialty chemicals company Evonik. Financial terms of the transaction have not been disclosed. Founded in 2012, JeNaCell produces biotechnology-derived nanocellulose, using the material as the basis for products aimed at clients in the medicine, pharmaceutical cosmetics and…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.